Today: August 28, 2015, 2:47 pm

C&M: Global Peripheral Vascular Stents market report published
MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts - a new market research report on 2014-03-17 00:38:02
The sales of peripheral vascular stents for the lower extremity in 2012 in the 10 major markets, reached $2.2 billion. We estimate 2013 sales of peripheral vascular stents for the lower extremity to be $2.3 billion across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India. Vascular stents used to treat PAD in the lower extremity include bare metal, drug-eluting, covered, and bioabsorbable stents.

Peripheral stenting is associated with improved clinical outcomes and quality of life for patients suffering from this debilitating disease. By the end of the forecast period, sales of peripheral vascular stents will grow to over $3.6 billion at a Compound Annual Growth Rate (CAGR) of 8%.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.